首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名：Expert opinion on orphan drugs

缩写：EXPERT OPIN ORPHAN D

ISSN：2167-8707

e-ISSN：

IF/分区：0.8/Q4

文章目录 更多期刊信息

共收录本刊相关文章索引91条
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Advances in the treatment of neuronal ceroid lipofuscinosis [0.03%]
Sondhi, Dolan; Rosenberg, Jonathan B; Van de Graaf et al. Sondhi et al.
Expert Opinion on Orphan Drugs. 2013;1(12):951-975. DOI:10.1517/21678707.2013.852081 2013
Malignant hyperthermia: current strategies for effective diagnosis and management [0.03%]
Wappler, Frank Wappler
Expert Opinion on Orphan Drugs. 2014;2(3):259-269. DOI:10.1517/21678707.2014.880648 2014
Current and investigational treatments for spinal muscular atrophy [0.03%]
Tam, Janice Kal Van; Karyka, Evangelia; Azzouz et al. Tam et al.
Expert Opinion on Orphan Drugs. 2014;2(5):465-476. DOI:10.1517/21678707.2014.901910 2014
State of the art: medical treatment of Peyronie's disease [0.03%]
Sicard, Kaitlen G; Aliperti, Louis A; Usta et al. Sicard et al.
Expert Opinion on Orphan Drugs. 2013;1(11):867-876. DOI:10.1517/21678707.2013.851026 2013
Treatment options in Huntington's disease [0.03%]
López-Sendón Moreno, José Luis; García de Yébenes, Justo López-Sendón Moreno
Expert Opinion on Orphan Drugs. 2013;1(11):901-914. DOI:10.1517/21678707.2013.851598 2013
Current and future therapies for Niemann–Pick C disease [0.03%]
Pineda, Mercedes; Perez-Poyato, Maria del Socorro Pineda
Expert Opinion on Orphan Drugs. 2013;1(11):915-923. DOI:10.1517/21678707.2013.849583 2013
Fueling the development of products for rare diseases: the impact of the FDA’s orphan products grants program [0.03%]
Imoisili, Menfo A; Mueller, Christine; Needleman et al. Imoisili et al.
Expert Opinion on Orphan Drugs. 2014;2(8):807-815. DOI:10.1517/21678707.2014.923305 2014
An overview of current and future treatment options for chondrosarcoma [0.03%]
Su, Chen-Ming; Fong, Yi-Chin; Tang et al. Su et al.
Expert Opinion on Orphan Drugs. 2014;2(3):217-227. DOI:10.1517/21678707.2014.874280 2014
An overview of current treatment strategies for β-thalassemia [0.03%]
Cappellini, Maria Domenica; Viprakasit, Vip; Taher et al. Cappellini et al.
Expert Opinion on Orphan Drugs. 2014;2(7):665-679. DOI:10.1517/21678707.2014.918503 2014
Droxidopa for the treatment of neurogenic orthostatic hypotension and other symptoms of neurodegenerative disorders [0.03%]
Perez-Lloret, Santiago; Rey, María Verónica; Pavy-Le Traon et al. Perez-Lloret et al.
Expert Opinion on Orphan Drugs. 2014;2(5):509-522. DOI:10.1517/21678707.2014.901167 2014